Douglas N. Homnick

905 total citations
25 papers, 634 citations indexed

About

Douglas N. Homnick is a scholar working on Pulmonary and Respiratory Medicine, Speech and Hearing and Psychiatry and Mental health. According to data from OpenAlex, Douglas N. Homnick has authored 25 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 5 papers in Speech and Hearing and 4 papers in Psychiatry and Mental health. Recurrent topics in Douglas N. Homnick's work include Cystic Fibrosis Research Advances (15 papers), Respiratory and Cough-Related Research (4 papers) and Tracheal and airway disorders (4 papers). Douglas N. Homnick is often cited by papers focused on Cystic Fibrosis Research Advances (15 papers), Respiratory and Cough-Related Research (4 papers) and Tracheal and airway disorders (4 papers). Douglas N. Homnick collaborates with scholars based in United States. Douglas N. Homnick's co-authors include John H. Marks, Dilip R. Patel, Heather L. VandenBussche, Helen D. Pratt, Robert A. Saunders, Samya Z. Nasr, Mary Kleyn, Steven J. Korzeniewski, William G. Young and Violanda Grigorescu and has published in prestigious journals such as Free Radical Biology and Medicine, CHEST Journal and The Journal of Pediatrics.

In The Last Decade

Douglas N. Homnick

24 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas N. Homnick United States 15 432 115 61 53 44 25 634
Ulf Bodechtel Germany 15 186 0.4× 79 0.7× 88 1.4× 39 0.7× 61 1.4× 47 704
Rebecca Affoo Canada 9 72 0.2× 177 1.5× 162 2.7× 124 2.3× 96 2.2× 27 495
Yumi Shiina Japan 15 214 0.5× 18 0.2× 33 0.5× 35 0.7× 159 3.6× 49 633
R. J. Shulman United States 12 185 0.4× 41 0.4× 104 1.7× 206 3.9× 79 1.8× 13 810
P. N. Suman Rao India 12 159 0.4× 41 0.4× 7 0.1× 35 0.7× 106 2.4× 22 464
Pok-yu Chow China 11 179 0.4× 22 0.2× 410 6.7× 35 0.7× 34 0.8× 13 623
Robert Fulcher United Kingdom 11 90 0.2× 105 0.9× 121 2.0× 44 0.8× 93 2.1× 19 456
Richard Debon France 16 129 0.3× 25 0.2× 53 0.9× 42 0.8× 207 4.7× 21 748
Ellen R. Brooks United States 14 67 0.2× 14 0.1× 135 2.2× 42 0.8× 47 1.1× 29 826
Donna L. Wilkes Canada 14 493 1.1× 51 0.4× 170 2.8× 67 1.3× 86 2.0× 19 832

Countries citing papers authored by Douglas N. Homnick

Since Specialization
Citations

This map shows the geographic impact of Douglas N. Homnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas N. Homnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas N. Homnick more than expected).

Fields of papers citing papers by Douglas N. Homnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas N. Homnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas N. Homnick. The network helps show where Douglas N. Homnick may publish in the future.

Co-authorship network of co-authors of Douglas N. Homnick

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas N. Homnick. A scholar is included among the top collaborators of Douglas N. Homnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas N. Homnick. Douglas N. Homnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Homnick, Douglas N., et al.. (2013). Effect of Therapeutic Horseback Riding on Balance in Community-Dwelling Older Adults with Balance Deficits. The Journal of Alternative and Complementary Medicine. 19(7). 622–626. 26 indexed citations
2.
VandenBussche, Heather L. & Douglas N. Homnick. (2012). Evaluation of Serum Concentrations Achieved With an Empiric Once-Daily Tobramycin Dosage Regimen in Children and Adults With Cystic Fibrosis. The Journal of Pediatric Pharmacology and Therapeutics. 17(1). 67–77. 14 indexed citations
3.
Kleyn, Mary, Ibrahim Abdulhamid, Catherine K. Allan, et al.. (2012). Evaluation of genetic counseling among cystic fibrosis carriers, Michigan Newborn Screening. Pediatric Pulmonology. 48(2). 123–129. 1 indexed citations
4.
Kleyn, Mary, Steven J. Korzeniewski, Violanda Grigorescu, et al.. (2010). Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis. Pediatric Pulmonology. 46(1). 23–30. 23 indexed citations
5.
Homnick, Douglas N., John H. Marks, & Bruce K. Rubin. (2007). The Effect of A First-Generation Antihistamine on Sputum Viscoelasticity in Cystic Fibrosis. Journal of Aerosol Medicine. 20(1). 45–49. 8 indexed citations
6.
Homnick, Douglas N.. (2007). Making airway clearance successful. Paediatric Respiratory Reviews. 8(1). 40–45. 20 indexed citations
7.
Homnick, Douglas N., et al.. (2007). Parent-Reported Physician Diagnosis Is an Important Factor in Asthma Management: An Elementary School Survey. Clinical Pediatrics. 46(5). 431–436. 1 indexed citations
8.
Homnick, Douglas N.. (2007). Mechanical Insufflation-Exsufflation for Airway Mucus Clearance. Respiratory Care. 52(10). 1296–1307. 98 indexed citations
9.
Homnick, Douglas N., et al.. (2005). Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis. Pediatric Pulmonology. 40(3). 251–256. 35 indexed citations
10.
Homnick, Douglas N., et al.. (2004). Cyproheptadine is an effective appetite stimulant in cystic fibrosis. Pediatric Pulmonology. 38(2). 129–134. 38 indexed citations
11.
Marks, John H., et al.. (2004). Pulmonary Function and Sputum Production in Patients With Cystic Fibrosis. CHEST Journal. 125(4). 1507–1511. 23 indexed citations
12.
Homnick, Douglas N. & Helen D. Pratt. (2000). Respiratory diseases with a psychosomatic component in adolescents.. PubMed. 11(3). 547–65. 14 indexed citations
13.
Homnick, Douglas N., et al.. (1999). Effects of Chronic Tobramycin Treatment on Distortion Product Otoacoustic Emissions. Ear and Hearing. 20(5). 393–402. 34 indexed citations
14.
Marks, John H., et al.. (1998). The Intrapulmonary Percussive Ventilator and Flutter Device Compared to Standard Chest Physiotherapy in Patients wit Cystic Fibrosis. Clinical Pediatrics. 37(7). 427–432. 43 indexed citations
15.
Homnick, Douglas N., et al.. (1996). . The Journal of Pediatrics. 129(1). 182–182.
16.
Homnick, Douglas N., et al.. (1995). Comparison of effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatric Pulmonology. 20(1). 50–55. 70 indexed citations
17.
Homnick, Douglas N., et al.. (1995). Single- and multiple-dose–response relationships of beta-carotene in cystic fibrosis. The Journal of Pediatrics. 127(3). 491–494. 18 indexed citations
18.
Homnick, Douglas N., et al.. (1993). Carotenoid levels in normal children and in children with cystic fibrosis. The Journal of Pediatrics. 122(5). 703–707. 58 indexed citations
19.
Homnick, Douglas N.. (1993). H-Type Tracheoesophageal Fistula and Congenital Esophageal Stenosis. CHEST Journal. 103(1). 308–309. 11 indexed citations
20.
Ralls, Jack W., et al.. (1973). IN‐PLANT, CONTINUOUS HOT‐GAS BLANCHING OF SPINACH. Journal of Food Science. 38(2). 192–194. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026